Advisory Boards

The CCF Advisory Boards consist of key opinion leaders, scientists, clinicians and healthcare providers who are active in the education, treatment, clinical and basic research of cholangiocarcinoma and are committed to furthering the CCF mission. Advisory Board members serve to guide the CCF with a diversity of perspectives, providing assistance and insight into the vision and mission of the CCF from a medical/scientific perspective. In addition, the Advisory Boards provide guidance on strategic medical and scientific direction for the Executive Board of Directors.

Medical Advisory

Chair, Ghassan K. Abou-Alfa, MD

Dr. Abou-Alfa is a board-certified medical oncologist who treats patients with gastrointestinal cancers. His specialization is in primary liver cancer (hepatocellular carcinoma), pancreas, gallbladder, and bile duct tumors. His research focuses on improving the effectiveness of cancer therapy by incorporating small novel biological molecules that target cancer into the treatment of chemotherapy-resistant gastrointestinal malignancies, particularly hepatobiliary and pancreatic...

Vice Chair, Juan Valle

Professor Juan Valle is a Professor of Medical Oncology in the University of Manchester (Institute of Cancer Studies); part of the Manchester Academic Health Sciences Centre. He is based in the Department of Medical Oncology at The Christie NHS Foundation Trust within the Gastrointestinal Disease Group and treats cancers of the pancreas, liver and biliary tract, neuroendocrine tumours and colorectal cancer. He is Head of Service for The Christie Neuroendocrine Team which has, under professor Valle’s leadership, been recognised as a Centre of Excellence for the treatment of patients with neuroendocrine tumours (NETs) by ENETS (the European Neuroendocrine Tumour Society). Prof. Valle is a member of the UK National Cancer Research Network (NCRN) Upper Gastrointestinal Clinical Studies Group and member of the hepatobiliary and...

Clinical Science
Advisory Board

Chair, Alan P. Venook, MD

Dr. Alan Venook is Professor of Clinical Medicine and the Madden Family Distinguished Professor of Medical Oncology and Translational Research at the University of California, San Francisco (UCSF). Dr. Venook hails from Metuchen, NJ; he received a BA in Biological Sciences from Rutgers College in 1976 (a year in which, as Sports Editor of the Rutgers Daily Targum he also sat courtside for the NCAA Final Four in Philadelphia, PA.) He received his MD Degree in 1980 from UCSF, completed his internship at UCSF in 1981, then spent two years at an Urban Indian clinic in Sacramento California (to fulfill a commitment to the public Health Service) and then completed a residency in Internal Medicine at the University of California, Davis. He returned to...

Vice Chair, Milind Javle, MD

Dr. Javle received his medical degree at Grant Medical College, University of Bombay, in Bombay, India. He then pursued postgraduate training in Internal Medicine at the State University of New York (SUNY) in Buffalo, NY, followed by a clinical fellowship in medical oncology at Roswell Park Cancer Institute in Buffalo, NY. He is a Professor of Gastrointestinal (GI) Medical Oncology at the MD Anderson Cancer Center in Houston, TX. He has served in the past as Assistant Professor of Medical Oncology at Roswell Park Cancer Institute and has been a faculty member at MD Anderson Cancer Center since 2007, in the GI Medical Oncology Division, with research interests in pancreatic and biliary cancers. His research interests include identification of molecular subtypes of pancreatic and...

Basic Science
Advisory Board

Chair, Nabeel Bardeesy, PhD

Dr Bardeesy is an Associate Professor of Medicine at Harvard Medical School and the Massachusetts General Hospital Cancer Center. He is the recipient of the Gallagher Endowed Chair in Gastrointestinal Cancer Research. His lab focuses on the interface of metabolism and epigenetic reprogramming in GI cancers and in the development of genetically engineered mouse models of human cancer. Dr Bardeesy received both his BS and  PhD in Biochemistry from McGill University in Canada, followed by a Postdoctoral Fellowship in Medical Oncology at the Dana-Farber Cancer Institute at Harvard Medical...

Vice Chair, Ben Stanger, MD PhD

Dr. Stanger is an Associate Professor of Medicine and Cell and Developmental Biology at the University of Pennsylvania, where he is a practicing gastroenterologist. His laboratory studies the intersection between development of the GI tract and gastrointestinal cancers, with an emphasis on the pancreas, liver, and biliary tract. Dr. Stanger received his SB degree from MIT and his MD and PhD in Genetics from Harvard Medical School. His did a residency in Internal Medicine UCSF and a clinical fellowship in Gastroenterology at Massachusetts General Hospital, followed by a postdoctoral research fellowship at Harvard...

General Science
Advisory Board